You're using an outdated browser. To get the most out of this website, as well as many others, please consider upgrading to a modern browser, such as Google Chrome, Mozilla Firefox, or Microsoft Edge.

Open menu


Evgen reveals results from pivotal phase 1b trial

Evgen Pharma – a company developing sulforaphane-based treatments – has announced top line pharmacokinetic data relating its dose-escalating, placebo-controlled, randomised phase 1/1b clinical trial.